Ajooni Accounts Payable vs Other Stockholder Equity Analysis

AJOONI Stock   7.54  0.19  2.46%   
Ajooni Biotech financial indicator trend analysis is way more than just evaluating Ajooni Biotech prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ajooni Biotech is a good investment. Please check the relationship between Ajooni Biotech Accounts Payable and its Other Stockholder Equity accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ajooni Biotech Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Accounts Payable vs Other Stockholder Equity

Accounts Payable vs Other Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ajooni Biotech Accounts Payable account and Other Stockholder Equity. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Ajooni Biotech's Accounts Payable and Other Stockholder Equity is 0.41. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Ajooni Biotech Limited, assuming nothing else is changed. The correlation between historical values of Ajooni Biotech's Accounts Payable and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Ajooni Biotech Limited are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Accounts Payable i.e., Ajooni Biotech's Accounts Payable and Other Stockholder Equity go up and down completely randomly.

Correlation Coefficient

0.41
Relationship DirectionPositive 
Relationship StrengthWeak

Accounts Payable

An accounting item on the balance sheet that represents Ajooni Biotech obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Ajooni Biotech are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Other Stockholder Equity

Most indicators from Ajooni Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ajooni Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ajooni Biotech Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
The current year's Selling General Administrative is expected to grow to about 8.3 M. The current year's Tax Provision is expected to grow to about 5.5 M
 2021 2022 2023 2024 (projected)
Gross Profit100.2M87.4M59.2M53.7M
Total Revenue740.4M744.9M801.1M451.3M

Ajooni Biotech fundamental ratios Correlations

0.730.970.570.90.740.110.130.190.870.740.990.980.20.90.90.020.870.830.680.510.530.31-0.010.760.57
0.730.550.840.510.920.110.13-0.140.370.980.710.630.520.480.770.020.810.330.650.540.890.77-0.070.680.86
0.970.550.410.920.590.080.10.260.940.560.970.980.040.940.83-0.010.790.90.610.390.340.1-0.050.70.41
0.570.840.410.510.75-0.28-0.270.160.240.820.60.50.330.450.5-0.190.760.330.420.440.850.7-0.330.750.74
0.90.510.920.510.55-0.04-0.030.420.80.550.940.94-0.10.90.7-0.190.820.860.540.510.370.120.060.760.43
0.740.920.590.750.55-0.1-0.07-0.190.410.870.720.660.320.530.76-0.270.860.330.670.370.70.52-0.140.760.91
0.110.110.08-0.28-0.04-0.11.0-0.060.060.160.070.10.15-0.030.180.6-0.070.00.040.290.230.360.62-0.18-0.02
0.130.130.1-0.27-0.03-0.071.0-0.080.070.180.090.120.17-0.020.20.6-0.050.010.070.30.240.370.61-0.170.0
0.19-0.140.260.160.42-0.19-0.06-0.080.32-0.090.290.31-0.450.48-0.03-0.220.190.52-0.40.130.09-0.07-0.090.46-0.16
0.870.370.940.240.80.410.060.070.320.360.860.890.010.940.70.030.590.940.40.250.14-0.1-0.160.590.16
0.740.980.560.820.550.870.160.18-0.090.360.710.630.560.50.780.080.780.380.610.710.880.780.090.640.8
0.990.710.970.60.940.720.070.090.290.860.710.990.090.930.85-0.070.890.850.610.490.540.29-0.040.820.57
0.980.630.980.50.940.660.10.120.310.890.630.990.010.940.83-0.070.860.870.60.440.450.21-0.010.790.52
0.20.520.040.33-0.10.320.150.17-0.450.010.560.090.01-0.060.450.590.08-0.020.370.470.420.540.02-0.110.16
0.90.480.940.450.90.53-0.03-0.020.480.940.50.930.94-0.060.68-0.150.720.960.340.390.320.04-0.140.770.32
0.90.770.830.50.70.760.180.2-0.030.70.780.850.830.450.680.190.820.610.790.520.550.410.070.610.62
0.020.02-0.01-0.19-0.19-0.270.60.6-0.220.030.08-0.07-0.070.59-0.150.19-0.250.010.120.240.110.330.26-0.47-0.26
0.870.810.790.760.820.86-0.07-0.050.190.590.780.890.860.080.720.82-0.250.560.710.390.690.46-0.110.90.83
0.830.330.90.330.860.330.00.010.520.940.380.850.87-0.020.960.610.010.560.260.440.19-0.05-0.070.60.1
0.680.650.610.420.540.670.040.07-0.40.40.610.610.60.370.340.790.120.710.260.260.410.340.030.370.61
0.510.540.390.440.510.370.290.30.130.250.710.490.440.470.390.520.240.390.440.260.520.490.570.270.29
0.530.890.340.850.370.70.230.240.090.140.880.540.450.420.320.550.110.690.190.410.520.94-0.050.630.76
0.310.770.10.70.120.520.360.37-0.07-0.10.780.290.210.540.040.410.330.46-0.050.340.490.940.070.340.64
-0.01-0.07-0.05-0.330.06-0.140.620.61-0.09-0.160.09-0.04-0.010.02-0.140.070.26-0.11-0.070.030.57-0.050.07-0.29-0.03
0.760.680.70.750.760.76-0.18-0.170.460.590.640.820.79-0.110.770.61-0.470.90.60.370.270.630.34-0.290.7
0.570.860.410.740.430.91-0.020.0-0.160.160.80.570.520.160.320.62-0.260.830.10.610.290.760.64-0.030.7
Click cells to compare fundamentals

Ajooni Biotech Account Relationship Matchups

Ajooni Biotech fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets230.7M280.3M290.2M587.3M475.2M499.0M
Total Current Liabilities58.5M104.8M100.6M152.1M30.1M58.3M
Total Stockholder Equity158.9M156.5M163.8M416.7M427.1M448.4M
Net Debt49.0M65.4M52.9M48.7M17.4M25.9M
Retained Earnings63.6M44.5M55M66.2M86.9M91.3M
Accounts Payable19.3M54.0M68.0M101.1M15.8M29.2M
Cash1.2M2.4M573.9K3.1M4.3M7.0M
Cash And Short Term Investments1.2M2.4M573.9K4.9M4.3M7.1M
Common Stock Shares Outstanding38.6M53.0M56.7M5.8M86.4M47.5M
Liabilities And Stockholders Equity230.7M280.3M290.2M587.3M475.2M499.0M
Other Stockholder Equity11.3M30.1M63.8M178.0M264.9M278.1M
Total Liab71.8M123.8M126.4M170.6M48.1M76.7M
Total Current Assets175.1M214.3M219.3M346.7M323.3M339.4M
Common Stock61.6M84.1M100.1M175.2M175.2M184.0M
Other Current Liab499.6K381.4K333.1K11.2M570K541.5K
Property Plant And Equipment Net20.7M51.6M62.1M65.5M112.4M118.1M
Non Current Assets Total55.6M66.0M70.9M240.6M151.9M80.7M
Non Currrent Assets Other2.8M1.4M(69.1M)15M15.0M8.0M
Net Receivables129.1M138.7M139.4M205.5M129.6M85.3M
Inventory32.9M53.8M58.8M69.9M180.6M189.6M
Other Current Assets141.0M11.5M12.7M268.6M34.6M58.8M
Non Current Liabilities Total13.3M19.0M25.8M18.5M18.0M22.0M
Short Long Term Debt Total50.3M67.8M53.5M51.8M21.7M20.6M
Short Term Debt36.9M48.9M27.7M34.3M4.9M4.6M
Long Term Debt13.3M19.0M25.8M17.5M20.1M12.4M
Short Term Investments661K1.6M1.2M1.8M22K20.9K
Long Term Debt Total13.3M19.0M25.8M17.5M20.1M13.5M
Property Plant Equipment20.7M51.6M62.1M65.5M75.3M79.1M
Net Tangible Assets158.9M156.5M163.8M416.7M479.2M503.2M
Current Deferred Revenue1.9M1.5M4.5M5.7M83K78.9K
Net Invested Capital209.2M224.3M217.3M468.5M538.7M274.7M
Short Long Term Debt36.9M48.9M27.7M34.3M39.4M33.9M
Non Current Liabilities Other(0.13)0.320.11(1.0)(0.9)(0.85)
Net Working Capital116.6M109.5M118.7M194.6M223.8M140.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Ajooni Stock

Balance Sheet is a snapshot of the financial position of Ajooni Biotech at a specified time, usually calculated after every quarter, six months, or one year. Ajooni Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Ajooni Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Ajooni currently owns. An asset can also be divided into two categories, current and non-current.